13 Einträge gefunden

1. Therapeutic Drug Monitoring of Naltrexone and 6β-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges

   1. Brünen, Sonja
   2. Bekier, Nina Kim
   3. Hiemke, Christoph
   4. Korf, Felix
   5. Wiedemann, Klaus
   6. Jahn, Holger
   7. Kiefer, Falk

   2019 - Forschungsinformationssystem des UKE
2. Augmented stress-induced alcohol drinking and withdrawal in mice lacking functional natriuretic peptide-A receptors.

   1. Mutschler, Jochen
   2. Bilbao, Ainhoa
   3. von der Goltz, Christoph
   4. Demiralay, Cüneyt
   5. Jahn, Holger
   6. Wiedemann, Klaus
   7. Spanagel, Rainer

   2010 - Forschungsinformationssystem des UKE
3. Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.

   1. Kiefer, Falk
   2. Jahn, Holger
   3. Otte, Christian
   4. Nakovics, Helmut
   5. Wiedemann, Klaus

   2006 - Forschungsinformationssystem des UKE
4. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?

   1. Kiefer, Falk
   2. Jahn, Holger
   3. Otte, Christian
   4. Naber, Dieter
   5. Wiedemann, Klaus

   2006 - Forschungsinformationssystem des UKE
5. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.

   1. Kiefer, Falk
   2. Helwig, Hauke
   3. Tarnaske, Timo
   4. Otte, Christian
   5. Jahn, Holger
   6. Wiedemann, Klaus

   2005 - Forschungsinformationssystem des UKE
6. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.

   1. Kiefer, Falk
   2. Jahn, Holger
   3. Otte, Christian
   4. Demiralay, Cüneyt
   5. Wolf, Karsten
   6. Wiedemann, Klaus

   2005 - Forschungsinformationssystem des UKE
7. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

   1. Jahn, Holger
   2. Schick, Mildred
   3. Kiefer, Falk
   4. Kellner, Michael
   5. Yassouridis, Alexander
   6. Wiedemann, Klaus

   2004 - Forschungsinformationssystem des UKE
8. Adjunctive use of reboxetine in schizophrenia.

   1. Raedler, Thomas J
   2. Jahn, Holger
   3. Arlt, Josef
   4. Kiefer, Falk
   5. Schick, Mildred
   6. Naber, Dieter
   7. Wiedemann, Klaus

   2004 - Forschungsinformationssystem des UKE
9. Involvement of NMDA receptors in alcohol-mediated behavior: mice with reduced affinity of the NMDA R1 glycine binding site display an attenuated sensitivity to ethanol.

   1. Kiefer, Falk
   2. Jahn, Holger
   3. Koester, Anja
   4. Montkowski, Alexandra
   5. Reinscheid, Rainer K
   6. Wiedemann, Klaus

   2003 - Forschungsinformationssystem des UKE
10. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

    1. Kiefer, Falk
    2. Jahn, Holger
    3. Tarnaske, Timo
    4. Helwig, Hauke
    5. Briken, Peer
    6. Holzbach, Rüdiger
    7. Kämpf, Philipp

    2003 - Forschungsinformationssystem des UKE
11. Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyrapone.

    1. Jahn, Holger
    2. Kiefer, Falk
    3. Schick, Mildred
    4. Yassouridis, Alexander
    5. Steiger, Axel
    6. Kellner, Michael
    7. Wiedemann, Klaus

    2003 - Forschungsinformationssystem des UKE
12. Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship.

    1. Kiefer, Falk
    2. Jahn, Holger
    3. Schick, Mildred
    4. Wiedemann, Klaus

    2002 - Forschungsinformationssystem des UKE
13. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?

    1. Kiefer, Falk
    2. Horntrich, Mirko
    3. Jahn, Holger
    4. Wiedemann, Klaus

    2002 - Forschungsinformationssystem des UKE